Jonas Bergquist: Difference between revisions

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
m (Text replacement - "= | date" to "= | date")
 
(114 intermediate revisions by 3 users not shown)
Line 1: Line 1:
[[File:Jonas Bergquist.png|200px|thumb|right|faculty.utah.edu]]
[[File:Jonas Bergquist.png|200px|thumb|right|faculty.utah.edu]]
'''Jonas Bergquist''', MD, PhD, is a Full Chair Professor in Analytical Chemistry and Neurochemistry at the Department of Chemistry at Uppsala University.<ref name=":0" /> He also has served as an Associate Professor of Clinical Neuroscience at the Sahlgrenska University Hospital and Gothenburg University, Gothenburg, Sweden. In 1999, he became a Researcher in Uppsala University, Uppsala, Sweden. In 2005, he was appointed the Chaired Professor of Analytical Chemistry and Neurochemistry, heading the Bergquist group at the Department of Chemistry, Biomedical Centre, Uppsala University. Since 2011, he is an Adjunct Professor of Pathology at the University of Utah, Salt Lake City, US, and since 2015, a Professor of Precision Medicine, Binzhou Medical University, Yantai, China.<ref name=":1">{{Cite web|url=http://katalog.uu.se/profile/?id=N99-791|title=Jonas Bergquist - Uppsala University, Sweden|last=Johansson|first=Åke|website=katalog.uu.se|language=en|access-date=2019-04-25}}</ref>
'''Jonas Bergquist''', MD, PhD, is a Full Chair Professor in Analytical Chemistry and Neurochemistry at the Department of Chemistry at Uppsala University.<ref name=":0" /> He also has served as an Associate Professor of Clinical Neuroscience at the Sahlgrenska University Hospital and Gothenburg University, Gothenburg, Sweden. In 1999, he became a Researcher in Uppsala University, Uppsala, Sweden. In 2005, he was appointed the Chaired Professor of Analytical Chemistry and Neurochemistry, heading the Bergquist group at the Department of Chemistry, Biomedical Centre, Uppsala University. Since 2011, he is an Adjunct Professor of Pathology at the University of Utah, Salt Lake City, US, and since 2015, a Professor of Precision Medicine, Binzhou Medical University, Yantai, China.<ref name=":1">{{Cite web | url = http://katalog.uu.se/profile/?id=N99-791 | title = Jonas Bergquist - Uppsala University, Sweden | last = Johansson | first = Åke|website=katalog.uu.se|language=en|access-date=2019-04-25}}</ref>


Research interests: various neurodegenerative diseases such as Parkinson's, [[Alzheimer's]], amyotrophic lateral sclerosis (ALS) and [[multiple sclerosis]] (MS); his research "involves methods to measure substances that can act as [[biomarker]]s for early diagnosis and contribute to the understanding of what initiates the disease process... [and] measure not only the individual substances but also seek patterns and monitor how they change during illness,... [the Bergquist group's] specialty is the analysis of cerebrospinal fluid and its chemical composition."<ref name=":1" />
Research interests: various neurodegenerative diseases such as Parkinson's, [[Alzheimer's]], amyotrophic lateral sclerosis (ALS) and [[multiple sclerosis]] (MS); his research "involves methods to measure substances that can act as [[biomarker]]s for early diagnosis and contribute to the understanding of what initiates the disease process... [and] measure not only the individual substances but also seek patterns and monitor how they change during illness,... [the Bergquist group's] specialty is the analysis of cerebrospinal fluid and its chemical composition."<ref name=":1" />


Dr Bergquist leads the [[Open Medicine Foundation|Open Medicine Foundation's]] center in Uppsala, Sweden.<ref>{{Cite web|url=https://www.omf.ngo/collaborative-center-uppsala/|title=Collaborative Center - Uppsala|last=|first=|authorlink=|last2=|first2=|authorlink2=|date=|website=[[Open Medicine Foundation]]|language=en-US|archive-url=|archive-date=|dead-url=|access-date=2020-08-15}}</ref>
Dr Bergquist leads the [[Open Medicine Foundation|Open Medicine Foundation's]] center in Uppsala, Sweden.<ref>{{Cite web | url = https://www.omf.ngo/collaborative-center-uppsala/ | title = Collaborative Center - Uppsala | last = | first = | authorlink = | date = | website = [[Open Medicine Foundation]]|language=en-US|archive-url=|archive-date=|url-status=|access-date=2020-08-15}}</ref>
 
==Long COVID ==
Professor Bergquist is principal investigator for the [[Open Medicine Foundation]]'s '''COVID-19 and ME/CFS study''', which was announced in May 2020.<ref>{{Cite web | date = 2020-06-17 | url = https://www.omf.ngo/2020/06/17/covid-19-and-me-news-flash-from-uppsala/ | title = COVID-19 and ME news flash from Uppsala | last = Open Medicine Foundation | first = | authorlink = Open Medicine Foundation|website=omf.org|archive-url=|archive-date=|url-status=|access-date=2020-09-19}}</ref>


==Working groups and committees==
==Working groups and committees==
===ME/CFS Collaborative Research Center at Stanford University===
===ME/CFS Collaborative Research Center at Stanford University===
Member of the Working Group which offers their expertise and resources to the [[ME/CFS Collaborative Research Center at Stanford University]].<ref>{{Cite web|url=https://bos.etapestry.com/prod/viewEmailAsPage.do?erRef=773.0.423082047&databaseId=OMF&mailingId=34274682&jobRef=773.0.506425459&key=b6b9237b3ebd1e462a5d11dbc5c4dae&personaRef=773.0.423082048&memberId=1348639685|title=OMF grants $1.2M to Ramp Up Collaborative Research Center at Stanford University|website=bos.etapestry.com|access-date=2019-04-25}}</ref>  
Member of the Working Group which offers their expertise and resources to the [[ME/CFS Collaborative Research Center at Stanford University]].<ref>{{Cite web | url = https://bos.etapestry.com/prod/viewEmailAsPage.do?erRef=773.0.423082047&databaseId=OMF&mailingId=34274682&jobRef=773.0.506425459&key=b6b9237b3ebd1e462a5d11dbc5c4dae&personaRef=773.0.423082048&memberId=1348639685 | title = OMF grants $1.2M to Ramp Up Collaborative Research Center at Stanford University|website=bos.etapestry.com|access-date=2019-04-25}}</ref>  


===EUROMENE===
===EUROMENE===
Dr. Bergquist is a member of the [[Biomarkers]] Working Group of [[ME/CFS]] across Europe on behalf of the [[EUROMENE]], a European Union COST Action CA15111 not-for-profit research organization committed to tackling the cause and treatment for [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]].<ref>{{Cite web|url=https://www.cost.eu/actions/CA15111/|title=Action CA15111|website=COST|language=en-GB|access-date=2019-04-25}}</ref>
Dr. Bergquist is a member of the [[Biomarkers]] Working Group of [[ME/CFS]] across Europe on behalf of the [[EUROMENE]], a European Union COST Action CA15111 not-for-profit research organization committed to tackling the cause and treatment for [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]].<ref>{{Cite web | url = https://www.cost.eu/actions/CA15111/ | title = Action CA15111 | website = COST|language=en-GB|access-date=2019-04-25}}</ref>


===ME/CFS Common Data Element (CDE) Project===
===ME/CFS Common Data Element (CDE) Project===
Member of the Biomarkers Working Group and Neurologic/Cognitive/CNS Imaging Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the [[National Institute of Neurological Disorders and Stroke]] and the [[Centers for Disease Control and Prevention]].<ref>{{Cite web|url=https://www.commondataelements.ninds.nih.gov/Myalgic%20Encephalomyelitis/Chronic%20Fatigue%20Syndrome#pane-138|title=Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster|last=|first=|authorlink=|last2=|first2=|authorlink2=|date=|website=NIH|archive-url=|archive-date=|dead-url=|access-date=2019-10-11}}</ref>
Member of the Biomarkers Working Group and Neurologic/Cognitive/CNS Imaging Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the [[National Institute of Neurological Disorders and Stroke]] and the [[Centers for Disease Control and Prevention]].<ref>{{Cite web | url = https://www.commondataelements.ninds.nih.gov/Myalgic%20Encephalomyelitis/Chronic%20Fatigue%20Syndrome#pane-138 | title = Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster | last = | first = | authorlink = | date = | website = NIH|archive-url=|archive-date=|url-status=|access-date=2019-10-11}}</ref>


==2017 Ramsay Award==
==2017 Ramsay Award==
A team comprised of Dr. Bergquist and Dr. [[Jonas Blomberg]] of Uppsala University and Dr. [[Carl-Gerhard Gottfries]] and Dr. Olof Zachrisson of the [[Gottfries Clinic]] were awarded a 2017 Ramsay Award grant from the [[Solve ME/CFS Initiative]] for research into [[biomarker]]s for initiation (infection) and metabolic derangement in [[ME/CFS]].<ref>{{Cite web|url=https://solvecfs.org/2017-ramsay-award-program-results/|title=2017 Ramsay Award Program Results|website=Solve ME/CFS Initiative|language=en-US|access-date=2019-04-25}}</ref>
A team comprised of Dr. Bergquist and Dr. [[Jonas Blomberg]] of Uppsala University and Dr. [[Carl-Gerhard Gottfries]] and Dr. Olof Zachrisson of the [[Gottfries Clinic]] were awarded a 2017 Ramsay Award grant from the [[Solve ME/CFS Initiative]] for research into [[biomarker]]s for initiation (infection) and metabolic derangement in [[ME/CFS]].<ref>{{Cite web | url = https://solvecfs.org/2017-ramsay-award-program-results/ | title = 2017 Ramsay Award Program Results|website=Solve ME/CFS Initiative|language=en-US|access-date=2019-04-25}}</ref>


==Talks and interviews==
==Talks and interviews==
*2015, [http://www.investinme.org/IIMEC10.shtml Speaker at the 10th Invest in ME International ME Conference - (no speech title given)] [http://www.investinme.org/IIMEC910.shtml#dvd DVD available]
*2015, Speaker at the 10th [[Invest in ME International ME Conference]]<ref>{{Cite web | url = http://www.investinme.org/IIMEC10.shtml | title = IIMEC10 International ME Conference 2015 | website = investinme.org|access-date=2021-05-11}}</ref> - (no speech title given) [http://www.investinme.org/IIMEC910.shtml#dvd DVD available]
*12 Aug 2017, [[Community Symposium on the Molecular Basis of ME/CFS - 2017]]: Speech title - [https://www.youtube.com/watch?v=Zsv5nbpliW8&list=PLl4AfLZNZEQOQG8vr4Rn_YY1E1cbFIu45&index=6 ''In search of biomarkers revealing pathophysiology in a Swedish ME/CFS patient cohort'']
*12 Aug 2017, [[Community Symposium on the Molecular Basis of ME/CFS - 2017]]: Speech title - [https://www.youtube.com/watch?v=Zsv5nbpliW8&list=PLl4AfLZNZEQOQG8vr4Rn_YY1E1cbFIu45&index=6 ''In search of biomarkers revealing pathophysiology in a Swedish ME/CFS patient cohort'']


* 3-5 May 2018, [[ME/CFS Canadian Collaborative Team Conference]] - Speech title: ''The Biochemistry to Support the Evidence of Neuroinflammatory Involvement in ME/CFS''<ref name=":0">{{Cite web|url=https://fourwaves-sots.s3.amazonaws.com/static/media/uploads/5FFGG5h0kBRlJTgexdugaQ%3D%3D/2018/04/24/me_cfs_final-program.pdf|title=ME/CFS Canadian Collaborative Team Conference program|last=|first=|authorlink=|last2=|first2=|authorlink2=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=2019-03-06}}</ref>
* 3-5 May 2018, [[ME/CFS Canadian Collaborative Team Conference]] - Speech title: ''The Biochemistry to Support the Evidence of Neuroinflammatory Involvement in ME/CFS''<ref name=":0">{{Cite web | url = https://fourwaves-sots.s3.amazonaws.com/static/media/uploads/5FFGG5h0kBRlJTgexdugaQ%3D%3D/2018/04/24/me_cfs_final-program.pdf | title=ME/CFS Canadian Collaborative Team Conference program | last = | first = | authorlink = | date = | website = |archive-url=|archive-date=|url-status=|access-date=2019-03-06}}</ref>
* 29 Sep 2018, ''The Neuroimmune Route in ME/CFS'', given at Second Annual [[Community Symposium on the Molecular Basis of ME/CFS - 2017|Community Symposium on the Molecular Basis of ME/CFS]], sponsored by [[Open Medicine Foundation]] - [https://www.youtube.com/watch?v=oXCEJxOmuAY&list=PLl4AfLZNZEQPxjqF4ojAO3wdCFMeriNBK&index=8 (Video)]
* 29 Sep 2018, ''The Neuroimmune Route in ME/CFS'', given at Second Annual [[Community Symposium on the Molecular Basis of ME/CFS - 2017|Community Symposium on the Molecular Basis of ME/CFS]], sponsored by [[Open Medicine Foundation]] - [https://www.youtube.com/watch?v=oXCEJxOmuAY&list=PLl4AfLZNZEQPxjqF4ojAO3wdCFMeriNBK&index=8 (Video)]
* 14 Mar 2019, [https://mecfsconference.org.au/videos/jonas-bergquist/ Targeted Molecular Diagnosis of ME/CFS – the Devil is in the Details], given at the [[International Research Symposium - Emerge Australia|International Research Symposium]], Geelong, Australia, sponsored by [[Emerge Australia]]
* 14 Mar 2019, [https://mecfsconference.org.au/videos/jonas-bergquist/ Targeted Molecular Diagnosis of ME/CFS – the Devil is in the Details], given at the [[International Research Symposium - Emerge Australia|International Research Symposium]], Geelong, Australia, sponsored by [[Emerge Australia]]
* 13 Apr 2021, UppTalk Weekly: With hope for the patients with ME, one of the world's most debilitating illnesses.<ref>{{Citation | title = UppTalk Weekly: With hope for the patients with ME, one of the worl'ds most debilitating illnesses. | url = https://www.youtube.com/watch?v=O2AT_xWpjnA|language=en|access-date=2021-05-11}}</ref>(Conversation in Swedish – subtitles in English) - [https://www.youtube.com/watch?v=O2AT_xWpjnA (Video)]


==Notable studies==
==Notable studies==
*2020, Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients – A validation study in plasma and cerebrospinal fluid from two Swedish cohorts<ref name="Bynke2020">{{Cite journal|last=Bynke|first=Annie|author-link=|last2=Julin|first2=Per|author-link2=|last3=Gottfries|first3=Carl-Gerhard|author-link3=Carl-Gerhard Gottfries|last4=Heidecke|first4=Harald|author-link4=|last5=Scheibenbogen|first5=Carmen|author-link5=Carmen Scheibenbogen|last6=Bergquist|first6=Jonas|author-link6=Jonas Bergquist|date=2020-08-01|title=Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients – A validation study in plasma and cerebrospinal fluid from two Swedish cohorts|url=http://www.sciencedirect.com/science/article/pii/S2666354620300727|journal=Brain, Behavior, & Immunity - Health|language=en|volume=7|issue=|pages=100107|doi=10.1016/j.bbih.2020.100107|issn=2666-3546|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [http://www.sciencedirect.com/science/article/pii/S2666354620300727 (Full text)]
*2022, Perspective: Drawing on Findings From Critical Illness to Explain Myalgic Encephalomyelitis/Chronic Fatigue Syndrome <ref>{{Cite journal | title = Perspective: Drawing on Findings From Critical Illness to Explain Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | date = 2022-03-08 | url = https://www.frontiersin.org/articles/10.3389/fmed.2022.818728/full|journal=Frontiers in Medicine|volume=9 | pages = 818728 | last = Stanculescu | first = Dominic | last2 = Bergquist | first2 = Jonas|doi=10.3389/fmed.2022.818728|issn=2296-858X}}</ref>
*2021, Lessons From Heat Stroke for Understanding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome <ref>{{Cite journal | last = Stanculescu | first = Dominic | last2 = Sepúlveda | first2 = Nuno | last3 = Lim | first3 = Chin Leong | last4 = Bergquist | first4 = Jonas | date = 2021 | title=Lessons From Heat Stroke for Understanding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | url = https://www.frontiersin.org/article/10.3389/fneur.2021.789784|journal=Frontiers in Neurology|volume=12 | pages = 2258|doi=10.3389/fneur.2021.789784|issn=1664-2295}}</ref>
*2021, Theory: Treatments for Prolonged ICU Patients May Provide New Therapeutic Avenues for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)<ref>{{Cite journal | last = Stanculescu | first = Dominic | last2 = Larsson | first2 = Lars | last3 = Bergquist | first3 = Jonas | date = 2021 | title=Theory: Treatments for Prolonged ICU Patients May Provide New Therapeutic Avenues for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | url = https://www.frontiersin.org/articles/10.3389/fmed.2021.672370/full|journal=Frontiers in Medicine|language=English|volume=8|doi=10.3389/fmed.2021.672370|issn=2296-858X}}</ref> - [https://www.frontiersin.org/articles/10.3389/fmed.2021.672370/full (Full text)]
*2021, Hypothesis: Mechanisms That Prevent Recovery in Prolonged ICU Patients Also Underlie Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)<ref>{{Cite journal | last = Stanculescu | first = Dominic | last2 = Larsson | first2 = Lars | last3 = Bergquist | first3 = Jonas | date = 2021-01-28 | title = Hypothesis: Mechanisms That Prevent Recovery in Prolonged ICU Patients Also Underlie Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | url = https://www.frontiersin.org/articles/10.3389/fmed.2021.628029/full|journal=Frontiers in Medicine|volume=8 | pages = 628029|doi=10.3389/fmed.2021.628029|issn=2296-858X|pmc=PMC7876311|pmid=33585528}}</ref> - [https://www.frontiersin.org/articles/10.3389/fmed.2021.628029/full (Full text)]
*2020, Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients – A validation study in plasma and cerebrospinal fluid from two Swedish cohorts<ref name="Bynke2020">{{Cite journal | last = Bynke | first = Annie | authorlink = | last2 = Julin | first2 = Per | authorlink2 = | last3 = Gottfries | first3 = Carl-Gerhard | authorlink3 = Carl-Gerhard Gottfries | last4 = Heidecke | first4 = Harald | authorlink4 = | last5 = Scheibenbogen | first5 = Carmen | authorlink5 = Carmen Scheibenbogen | last6 = Bergquist | first6 = Jonas | authorlink6 = Jonas Bergquist | date = 2020-08-01 | title = Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients – A validation study in plasma and cerebrospinal fluid from two Swedish cohorts | url = http://www.sciencedirect.com/science/article/pii/S2666354620300727|journal=Brain, Behavior, & Immunity - Health|language=en|volume=7|issue=|pages=100107|doi=10.1016/j.bbih.2020.100107|issn=2666-3546|pmc=|pmid=|access-date=|quote=|via=}}</ref> - [http://www.sciencedirect.com/science/article/pii/S2666354620300727 (Full text)]
*2011, Distinct Cerebrospinal Fluid Proteomes Differentiate Post-Treatment Lyme Disease from Chronic Fatigue Syndrome<ref name="Schutzer, 2011" /> - [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0017287 (Full Text)]
*2011, Distinct Cerebrospinal Fluid Proteomes Differentiate Post-Treatment Lyme Disease from Chronic Fatigue Syndrome<ref name="Schutzer, 2011" /> - [http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0017287 (Full Text)]
==Learn more ==
==See also ==
==See also ==
*[[Autoimmune hypothesis]]
*[[Autoimmune hypothesis]]
*[[Open Medicine Foundation]]
*[[Open Medicine Foundation]]
*[[Sweden]]
*[[Sweden]]
== Learn more ==


==References==
==References==
<references>
<references>
<ref name="Schutzer, 2011">{{Citation
<ref name="Schutzer, 2011">{{Citation | last1 = Schutzer | first1 = Steven E | authorlink1 = | last2 = Angel | first2 = Thomas E. | authorlink2 = | last3 = Liu | first3 = Tao | authorlink3 = | last4 = Schepmoes | first4 = Athena A. | authorlink4 = | last5 = Clauss | first5 = Therese R. | authorlink5 = | last6 = Adkins | first6 = Joshua N. | authorlink6 = | last7 = Camp | first7 = David G. | authorlink7 = | last8 = Holland | first8 = Bart K. | authorlink8 = | last9 = Bergquist | first9 = Jonas | authorlink9 = Jonas Bergquist | last10 = Coyle | first10 = Patricia K. | authorlink10 = | last11 = Smith | first11 = RichardD. | authorlink11 = | last12 = Fallon | first12 = Brian A. | authorlink12 = | last13 = Natelson | first13 = Benjamin | authorlink13 = Benjamin Natelson | title =  Distinct Cerebrospinal Fluid Proteomes Differentiate Post-Treatment Lyme Disease from Chronic Fatigue Syndrome | journal = PLoS ONE | volume = 6 | issue = 2 | page = | date = 2011 | doi = 10.1371/journal.pone.0017287 }}</ref>
| last1   = Schutzer       | first1 = Steven E           | authorlink1 =  
| last2   = Angel           | first2 = Thomas E.         | authorlink2 =  
| last3   = Liu             | first3 = Tao               | authorlink3 =  
| last4   = Schepmoes       | first4 = Athena A.         | authorlink4 =  
| last5   = Clauss         | first5 = Therese R.         | authorlink5 =  
| last6   = Adkins         | first6 = Joshua N.         | authorlink6 =  
| last7   = Camp           | first7 = David G.           | authorlink7 =  
| last8   = Holland         | first8 = Bart K.           | authorlink8 =  
| last9   = Bergquist       | first9 = Jonas             | authorlink9 = Jonas Bergquist
| last10 = Coyle           | first10 = Patricia K.       | authorlink10 =  
| last11 = Smith           | first11 = Richard D.       | authorlink11 =  
| last12 = Fallon         | first12 = Brian A.         | authorlink12 =  
| last13 = Natelson       | first13 = Benjamin         | authorlink13 = Benjamin Natelson
| title   =  Distinct Cerebrospinal Fluid Proteomes Differentiate Post-Treatment Lyme Disease from Chronic Fatigue Syndrome
| journal = PLoS ONE   | volume = 6   | issue = 2   | page =  
| date   = 2011
| doi     = 10.1371/journal.pone.0017287
}}
</ref>
</references>
</references>


[[Category:Researchers]]
[[Category:Researchers]]
[[Category:Sweden researchers]]
[[Category:Sweden researchers]]
[[Category:Long covid]]
[[Category:Long COVID researchers]]

Latest revision as of 15:15, April 2, 2023

faculty.utah.edu

Jonas Bergquist, MD, PhD, is a Full Chair Professor in Analytical Chemistry and Neurochemistry at the Department of Chemistry at Uppsala University.[1] He also has served as an Associate Professor of Clinical Neuroscience at the Sahlgrenska University Hospital and Gothenburg University, Gothenburg, Sweden. In 1999, he became a Researcher in Uppsala University, Uppsala, Sweden. In 2005, he was appointed the Chaired Professor of Analytical Chemistry and Neurochemistry, heading the Bergquist group at the Department of Chemistry, Biomedical Centre, Uppsala University. Since 2011, he is an Adjunct Professor of Pathology at the University of Utah, Salt Lake City, US, and since 2015, a Professor of Precision Medicine, Binzhou Medical University, Yantai, China.[2]

Research interests: various neurodegenerative diseases such as Parkinson's, Alzheimer's, amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS); his research "involves methods to measure substances that can act as biomarkers for early diagnosis and contribute to the understanding of what initiates the disease process... [and] measure not only the individual substances but also seek patterns and monitor how they change during illness,... [the Bergquist group's] specialty is the analysis of cerebrospinal fluid and its chemical composition."[2]

Dr Bergquist leads the Open Medicine Foundation's center in Uppsala, Sweden.[3]

Long COVID[edit | edit source]

Professor Bergquist is principal investigator for the Open Medicine Foundation's COVID-19 and ME/CFS study, which was announced in May 2020.[4]

Working groups and committees[edit | edit source]

ME/CFS Collaborative Research Center at Stanford University[edit | edit source]

Member of the Working Group which offers their expertise and resources to the ME/CFS Collaborative Research Center at Stanford University.[5]

EUROMENE[edit | edit source]

Dr. Bergquist is a member of the Biomarkers Working Group of ME/CFS across Europe on behalf of the EUROMENE, a European Union COST Action CA15111 not-for-profit research organization committed to tackling the cause and treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.[6]

ME/CFS Common Data Element (CDE) Project[edit | edit source]

Member of the Biomarkers Working Group and Neurologic/Cognitive/CNS Imaging Working Group of the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Common Data Element (CDE) Project sponsored by the National Institute of Neurological Disorders and Stroke and the Centers for Disease Control and Prevention.[7]

2017 Ramsay Award[edit | edit source]

A team comprised of Dr. Bergquist and Dr. Jonas Blomberg of Uppsala University and Dr. Carl-Gerhard Gottfries and Dr. Olof Zachrisson of the Gottfries Clinic were awarded a 2017 Ramsay Award grant from the Solve ME/CFS Initiative for research into biomarkers for initiation (infection) and metabolic derangement in ME/CFS.[8]

Talks and interviews[edit | edit source]

Notable studies[edit | edit source]

  • 2022, Perspective: Drawing on Findings From Critical Illness to Explain Myalgic Encephalomyelitis/Chronic Fatigue Syndrome [11]
  • 2021, Lessons From Heat Stroke for Understanding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome [12]
  • 2021, Theory: Treatments for Prolonged ICU Patients May Provide New Therapeutic Avenues for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)[13] - (Full text)
  • 2021, Hypothesis: Mechanisms That Prevent Recovery in Prolonged ICU Patients Also Underlie Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)[14] - (Full text)
  • 2020, Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients – A validation study in plasma and cerebrospinal fluid from two Swedish cohorts[15] - (Full text)
  • 2011, Distinct Cerebrospinal Fluid Proteomes Differentiate Post-Treatment Lyme Disease from Chronic Fatigue Syndrome[16] - (Full Text)

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. 1.0 1.1 "ME/CFS Canadian Collaborative Team Conference program" (PDF). Retrieved March 6, 2019.
  2. 2.0 2.1 Johansson, Åke. "Jonas Bergquist - Uppsala University, Sweden". katalog.uu.se. Retrieved April 25, 2019.
  3. "Collaborative Center - Uppsala". Open Medicine Foundation. Retrieved August 15, 2020.
  4. Open Medicine Foundation (June 17, 2020). "COVID-19 and ME news flash from Uppsala". omf.org. Retrieved September 19, 2020.
  5. "OMF grants $1.2M to Ramp Up Collaborative Research Center at Stanford University". bos.etapestry.com. Retrieved April 25, 2019.
  6. "Action CA15111". COST. Retrieved April 25, 2019.
  7. "Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster". NIH. Retrieved October 11, 2019.
  8. "2017 Ramsay Award Program Results". Solve ME/CFS Initiative. Retrieved April 25, 2019.
  9. "IIMEC10 International ME Conference 2015". investinme.org. Retrieved May 11, 2021.
  10. UppTalk Weekly: With hope for the patients with ME, one of the worl'ds most debilitating illnesses., retrieved May 11, 2021
  11. Stanculescu, Dominic; Bergquist, Jonas (March 8, 2022). "Perspective: Drawing on Findings From Critical Illness to Explain Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Frontiers in Medicine. 9: 818728. doi:10.3389/fmed.2022.818728. ISSN 2296-858X.
  12. Stanculescu, Dominic; Sepúlveda, Nuno; Lim, Chin Leong; Bergquist, Jonas (2021). "Lessons From Heat Stroke for Understanding Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Frontiers in Neurology. 12: 2258. doi:10.3389/fneur.2021.789784. ISSN 1664-2295.
  13. Stanculescu, Dominic; Larsson, Lars; Bergquist, Jonas (2021). "Theory: Treatments for Prolonged ICU Patients May Provide New Therapeutic Avenues for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)". Frontiers in Medicine. 8. doi:10.3389/fmed.2021.672370. ISSN 2296-858X.
  14. Stanculescu, Dominic; Larsson, Lars; Bergquist, Jonas (January 28, 2021). "Hypothesis: Mechanisms That Prevent Recovery in Prolonged ICU Patients Also Underlie Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)". Frontiers in Medicine. 8: 628029. doi:10.3389/fmed.2021.628029. ISSN 2296-858X. PMC 7876311. PMID 33585528.
  15. Bynke, Annie; Julin, Per; Gottfries, Carl-Gerhard; Heidecke, Harald; Scheibenbogen, Carmen; Bergquist, Jonas (August 1, 2020). "Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients – A validation study in plasma and cerebrospinal fluid from two Swedish cohorts". Brain, Behavior, & Immunity - Health. 7: 100107. doi:10.1016/j.bbih.2020.100107. ISSN 2666-3546.
  16. Schutzer, Steven E; Angel, Thomas E.; Liu, Tao; Schepmoes, Athena A.; Clauss, Therese R.; Adkins, Joshua N.; Camp, David G.; Holland, Bart K.; Bergquist, Jonas; Coyle, Patricia K.; Smith, RichardD.; Fallon, Brian A.; Natelson, Benjamin (2011), "Distinct Cerebrospinal Fluid Proteomes Differentiate Post-Treatment Lyme Disease from Chronic Fatigue Syndrome", PLoS ONE, 6 (2), doi:10.1371/journal.pone.0017287